Volume 26, Number 3—March 2020
Research
Genomic and Phenotypic Variability in Neisseria gonorrhoeae Antimicrobial Susceptibility, England
Table 1
Characteristics | Lineage, no. |
Lineage A outcomes |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Univariate |
Multivariable |
|||||||||
A | B | cOR | 95% CI | p value | aOR | 95% CI | p value | |||
Total |
838 |
439 |
||||||||
Year | ||||||||||
2013 | 220 | 106 | Ref | |||||||
2014 | 210 | 123 | 0.82 | 0.60–1.13 | 0.234 | |||||
2015 | 260 | 107 | 1.17 | 0.85–1.62 | 0.339 | |||||
2016 |
148 |
103 |
0.69 |
0.49–0.98 |
0.035 |
|||||
Clinic location | ||||||||||
Outside London | 630 | 136 | Ref | Ref | ||||||
London |
463 |
109 |
3.73 |
2.86–4.88 |
<0.001 |
1.74 |
1.27–2.67 |
0.001 |
||
Sex and sexual orientation | ||||||||||
MSM | 630 | 136 | Ref | Ref | ||||||
MSW | 150 | 154 | 0.21 | 0.15–0.29 | <0.001 | 0.33 | 0.23–0.47 | <0.001 | ||
F |
57 |
149 |
0.08 |
0.05–0.12 |
<0.001 |
0.14 |
0.09–0.22 |
<0.001 |
||
Age, y | ||||||||||
≤24 | 188 | 196 | Ref | Ref | ||||||
25–34 | 342 | 161 | 2.21 | 1.67–2.93 | <0.001 | 1.14 | 0.83–1.59 | 0.413 | ||
≥35 |
308 |
82 |
3.92 |
2.81–5.46 |
<0.001 |
1.68 |
1.16–2.40 |
0.006 |
||
Ethnicity | ||||||||||
White | 586 | 238 | Ref | Ref | ||||||
Black Caribbean | 51 | 81 | 0.26 | 0.17–0.38 | <0.001 | 0.49 | 0.32–0.76 | 0.001 | ||
Black African | 27 | 20 | 0.55 | 0.30–1.00 | 0.046 | 0.84 | 0.43–1.64 | 0.607 | ||
Black Other | 6 | 4 | 0.61 | 0.17–2.18 | 0.442 | 0.57 | 0.14–2.37 | 0.441 | ||
Asian | 57 | 17 | 1.36 | 0.78–2.39 | 0.280 | 1.86 | 1.01–3.45 | 0.048 | ||
Other | 24 | 8 | 1.22 | 0.54–2.75 | 0.634 | 0.99 | 0.41–2.44 | 0.999 | ||
Mixed |
62 |
43 |
0.59 |
0.39–0.89 |
0.011 |
0.82 |
0.51–1.32 |
0.413 |
||
Place of birth | ||||||||||
United Kingdom | 473 | 309 | Ref | |||||||
Not United Kingdom |
305 |
102 |
1.95 |
1.49–2.56 |
<0.001 |
|||||
Symptomatic infection | ||||||||||
No | 219 | 119 | Ref | |||||||
Yes |
526 |
277 |
1.03 |
0.79–1.35 |
0.818 |
|||||
New STI diagnosis <1 year, excluding HIV | ||||||||||
No or unknown | 615 | 363 | Ref | |||||||
Yes |
223 |
75 |
1.75 |
1.31–2.35 |
<0.001 |
|||||
HIV status | ||||||||||
Negative or unknown | 653 | 398 | Ref | |||||||
Positive |
185 |
41 |
2.75 |
1.91–3.96 |
<0.001 |
|||||
Number of partners in the United Kingdom <3 months of diagnosis | ||||||||||
0 | 27 | 20 | Ref | |||||||
1 | 175 | 162 | 0.80 | 0.43–1.48 | 0.478 | |||||
≥2 |
304 |
167 |
1.35 |
0.73–2.48 |
0.335 |
|||||
Travel-associated sexual partnerships <3 months of diagnosis | ||||||||||
No | 442 | 325 | Ref | |||||||
Yes | 64 | 24 | 1.96 | 1.20–3.21 | 0.006 |
*The multivariable model was adjusted for location, gender and sexual orientation, age, and ethnicity. Bold text indicates statistical significance (p<0.05 and 95% CI does not cross 1.0). aOR, adjusted odds ratio; cOR, crude odds ratio; MSM, men who have sex with men; MSW, men who reported sexual activity exclusively with women; Ref, referent; STI, sexually transmitted infection.
Page created: February 20, 2020
Page updated: February 20, 2020
Page reviewed: February 20, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.